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E-mail address: charken@health.sdu.dk (C.H. JenseDelta-like 1 (Dlk1) is expressed in 3T3-L1 preadipocytes and has frequently been referred to as ‘‘the”
preadipocyte marker, yet the phenotype of DLK1+ cells in adipose tissue remains undetermined.
Herein, we demonstrate that DLK1+ cells encompass around 1–2% of the adult mouse adipose stro-
mal vascular fraction (SVF). Unexpectedly, the DLK1+SVF population was enriched for cells express-
ing genes generally ascribed to the vascular lineage and did not possess any adipogenic
differentiation potential in vitro. Instead, DLK1+ cells comprised an immediate ability for cobble-
stone formation, generation of tube-like structures on matrigel, and uptake of Acetylated Low Den-
sity-Lipoprotein, all characteristics of endothelial cells. We therefore suggest that DLK1+SVF cells are
of a vascular origin and not them-selves committed preadipocytes as assumed hitherto.
 2009 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
The imprinted gene Dlk1, encodes a transmembrane protein
that may act as a Notch1 antagonist [1]. DLK1 is expressed in sev-
eral species and tissues during development, but downregulated
postnatally [2–6]. A soluble form of DLK1 [7] is generated by ecto-
domain shedding [8], and both forms are active in the prolifera-
tion/differentiation processes of various cell types [4,6,9–11],
adipogenesis being the most studied [12]. Adipose tissue forms rel-
atively late in development and recently it was shown that in nor-
mal humans, adipocyte expansion occurs from age 5–19 years and
10% of the fat cells are renewed annually throughout adulthood
implying differentiation and possibly, proliferation of existing
adult fat progenitors [13]. Dlk1 mRNA has been demonstrated in
adipose tissue of mouse e16.5 embryos [5] and persists in adipose
tissue from young [14–17] and adult animals, where it localizes to
the stromal vascular fraction (SVF) rather than mature adipocytes
[16–20]. While the SVF harbors preadipocytes, it also contains
many other cell types and the role of DLK1 in adipogenesis has
mainly been studied using the 3T3-L1 cell line. 3T3-L1 preadipo-chemical Societies. Published by E
munology and Microbiology,
21.1, DK-5000 Odense C,
n).cytes express DLK1 at high levels, but upon adipogenic induction,
DLK1 expression decreases and is abolished in mature adipocytes
[12,21,22]. Constitutive DLK1 expression in 3T3-L1 cells inhibits
adipogenesis whereas Dlk1 antisense transfection has the opposite
effect [22]. These in vitro effects are recapitulated in vivo where
DLK1 null mice reveal increased amounts of adipose tissue and adi-
pocyte hypertrophy [23], while mice overexpressing DLK1, possess
lower fat deposits than normal [14].
A number of studies have thus described Dlk1 in adipose tissue
[14–16,18,19] and referred to Dlk1 as ‘‘the preadipocyte marker”
but to our knowledge the present study is the ﬁrst describing an
actual localization and phenotype of DLK1+ cells in adult adipose
tissue.
2. Materials and methods
2.1. Isolation of SVF and in vitro cell culture
The SVF was freshly isolated/sorted (with no in vitro expan-
sion) from 10 to 12 weeks female NMRI mice (Taconic Europe,
Denmark), as previously described [24], and the preadipocyte
3T3-L1 as well as the myoblast cell line C2C12 were kept in
agreement with general guidelines. Adipogenic differentiation
was induced with DMEM/20% fetal calf serum (FCS)/1%PS or
DMEM/10%FCS/10% horse serum/1%PS supplemented with 1 lMlsevier B.V. All rights reserved.
2948 D.C. Andersen et al. / FEBS Letters 583 (2009) 2947–2953Dexamethasone (Dex; Sigma), 0.5 mM 3-Isobutyl-1-methylxan-
thine (Imbx, Sigma), 10 lg/mL Insulin (Sigma) for up to 21 days
with medium changes every 3 days. Adipogenesis was veriﬁed
by oil-red o staining (Sigma) as described previously [25]. For
endothelial differentiation, freshly sorted cells were plated in
ﬁbronectin (BD Falcon) or matrigel (BD Biosciences) coated 12-
well multidishes, and cultured in EGM2 (Lonza) as described pre-
viously [26]. Endothelial differentiation was assessed by ﬂowcy-
tometric analysis of DiI conjugated Ac-LDL uptake as
recommended by the manufacturer, and ﬁbroblasts (kind gift
from Hasse B. Jensen, University of Southern Denmark) were
used as a negative control.
2.2. Flowcytometry, cell sorting, antibodies, and immunostaining
Freshly isolated SVF cells were immediately used for ﬂowcy-
tometric analysis (BD FACS Calibur) or cell sorting (BD FACSVan-
tageSE/DiVa cell sorter (BD Bioscience)). Cell sorting was
performed as previously described [24,27]. The detailed sortingFig. 1. Characterization of mouse adipose tissue derived SVF–DLK1+ cells. (A–E) Immun
tissue derived from adult (10–12 weeks) animals, (D) cultured SVF cells, and (E) 3T3-L1 p
(A–C), 100 lm (D), and 250 lm (E)). (F) Relative qRT-PCR of Dlk1 in SVF and 3T3-L1 prea
sorted (for FACS strategy see Fig. S1) DLK1± and SVF cells. Data represent the mean ±
respectively), each comprising triplicate qRT-PCR on cells pooled from two independent
PCR analyses, data were normalized against multiple stably expressed control genes (Fig
for CD45, CD31, and FLK1. Percentages represent the mean ± S.D. (n = 3–6, n* = 3 mice) aft
(data not shown).strategy is shown online in Supplementary Fig. S1. For in vitro
studies, cells were sorted into DMEM/20%FCS/1%PS or EGM2, while
cells destined for RNA analysis were sorted directly into RNA Lysis-
buffer (2X) (Applied Biosystems (ABI)). Immuno(histo/cyto)chemi-
cal stainings were performed as previously described [6,24,26,27].
Rat monoclonals, APC-Cy7-CD45 (30F11; 1:50), PE-FLK1 (Ava-
s12a1, 1:50), CD31 (MEC. 13.; 1:50) and proper ± ﬂuorescence con-
jugated isotype-rat IgG2a (R35-95), -rat IgG2b (A95-1), and -rat
IgG2b (eB149/10H5) controls, were purchased from BD PharMingen
or eBiosciences. Rabbit a-mouse DLK1 [6] ((1:500 for FACS and
immunohistochemistry; 1:4000 for Immunocytochemistry)) and
nonsense control (in house) were either conjugated to ALEXA-
647 according to manufactures recommendations (Molecular
probes) or used together with Goat anti-rabbit-PE (Invitrogen,
1:200). Goat a-desmin (1:50), Goat a-CD31 (1:50) (Santa Cruz
technology) and a-aSMA (1:200, DSHB) were used for immunocy-
tochemistry as described previously [26]. Secondary antibodies
used were Alexa 555, 488 or 647 donkey a-rabbit, a-goat or a-
rat Ig (1:200, Molecular Probes), Envision-HRP detection systemostaining of DLK1 in (A and C) immature- and (B) mature mouse gonadal adipose
readipocytes. (B) No background staining was observed (scale bars represent 30 lm
dipocytes. (G and H) Simultaneous qRT-PCR of 42 genes (see also Fig. S3) in freshly
S.D. relative mRNA level in two independent experiments (white and black bars,
DLK1± cell sortings on fat derived from ﬁve mice each. (F–H) To obtain robust qRT-
. S2) as recommended by others [29]. (I) Flowcytometric analysis of DLK1+ SVF cells
er subtraction of the background as determined from corresponding isotype controls
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tor Lab).
2.3. sDLK1/FA1 ELISA
Quantiﬁcation of soluble mouse DLK1/FA1 was performed by
ELISA as previously described [12,28].Fig. 2. DLK1+-SVF cells lack adipogenic differentiation potential. DLK1±-SVF as well as SV
three days of proliferation (Day 0–3) followed by adipogenic differentiation for 15 days,
was performed. Only selected gene expression proﬁles are shown including adipogen
endothelial cells, and ﬁnally Dlk1. Data represent the mean ± S.D. relative mRNA level
derived from two independent DLK1± cell sortings on fat derived from ﬁve mice each.2.4. Relative quantitative RT-PCR array
Simultaneous relative qRT-PCR of 42 genes including 9 endoge-
nous controls was performed as previously described [24,27],
including normalization against multiple stably expressed control
genes using the geNorm [29] and qBase [30] software platforms
(Fig. S2).F cells were freshly prepared and sorted (Fig. S1) from adult mice, and cultured for
where after simultaneous qRT-PCR of 42 genes (see Fig. S2 for data normalization)
ic factors (Pparg2, Cebpb, adiponectin), a large variety of genes associated with
from three triplicate qRT-PCR measurements on cells pooled from 3  2 12-wells
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3.1. DLK1+ cells are found within the stromal vascular fraction (SVF) of
mouse adipose tissue
Immunohistochemistry showed that DLK1 is expressed in
cells lining a few small vessels scattered throughout areas
identiﬁed as immature fat [31] (Fig. 1A and C), but not in matureFig. 3. Isolation and characterization of the DLK1±/CD45-SVF subpopulations. Flowcytom
(A) a second round of cell sorting, (B) PCR (pituitary gland represents a positive control [
200 lm). (D) Immunocytochemistry for DLK1, aSMA, and desmin in freshly sorted DLK1
C2C12 myoblasts were included as a positive (aSMA/desmin) and a negative (DLK1) cont
and F) DLK1±/CD45-SVF as well as CD45-SVF cells were freshly prepared from adult m
adipogenic differentiation (including horse serum to improve adipogenic differentiation)
SVF cell cultures that revealed numerous cobblestones but no signs of vacuole containing
DLK1/CD45-SVF and CD45-SVF (data not shown) cell cultures comprised many matur
bars 250 lm).adipose tissue (Fig. 1B). In agreement with previous
studies [16–19,24], Dlk1 mRNA was present in the freshly iso-
lated SVF (Fig. 1F and G), and immunocytochemistry veriﬁed this
at the protein level (Fig. 1D). The exclusive DLK1 localization in
immature fat was reﬂected by the relative scarcity of SVF-
DLK1+ cells as analyzed by ﬂowcytometry (2.24 ± 0.24%
(mean ± S.D.; n = 3, n* = 5–10) (data not shown, but
see Fig. S1)).etric cell sorting of DLK1+/CD45-SVF and the purity of sorted cells as estimated by
3,4]), and (C) immunocytochemistry for DLK1 (green)/DAPI (blue)/phase (scale bars
+/CD45-SVF cells that were allowed to attach for 20 h to ﬁbronectin coated wells.
rol [2], whereas 3T3-L1 preadipocytes represent the opposite (scale bars 100 lm). (E
ice, and cultured on ﬁbronectin for three days of proliferation (Day 0–3) followed by
for 18 days. Representative microscopic phase pictures are shown for DLK1+/CD45-
cells, and a complete lack of Oil-red O staining (data not shown). (F) In contrast, both
e adipocytes as visualized by lipid ﬁlled Oil-red O+ droplets. (For both E and F, scale
D.C. Andersen et al. / FEBS Letters 583 (2009) 2947–2953 29513.2. The SVF-DLK1+ cells reveal an endothelial gene signature, but no
adipogenic potential
We isolated DLK1+ cells by FACS (Fig. S1) and performed relative
qRT-PCR between SVF–DLK1+, SVF–DLK1 and the parent SVF
(Fig. 1G and H and S2, S3). Dlk1 itself was found at 50-fold higher
levels in DLK1+ compared to DLK1 cells (Fig. 1G), conﬁrming the
enrichment achieved by cell sorting. In comparison with the SVF,
also 3T3-L1 preadipocytes expressed 50-fold more Dlk1 mRNA
(Fig. 1F), suggesting similar relative Dlk1 levels in our SVF–DLK1+
cells and a ‘‘pure” preadipocytic population (Fig. 1F and G). None-
theless, the SVF–DLK1+ cells expressed relatively low amounts of
adipocytic- (Pparc2, Wnt10b, Adiponectin; Fig. 1H) and mesenchy-
mal markers (Fig. S3), and instead this population appeared to be
enriched for cells expressing various transcripts generally associ-
ated with cells of the vascular lineage [32,33] (Fig. 1H). Flowcytom-
etry veriﬁed that subpopulations of SVF–DLK1+ cells expressed
CD45, CD31, and FLK1 (Fig. 1I).
We next studied the in vitro adipogenic potential of freshly
sorted SVF–DLK1+, SVF–DLK1, and parent SVF cells under stan-
dard adipogenic differentiation conditions [12,34]. After 15 days
of differentiation, no apparent adipogenic induction was observed
in DLK1+ cultures, whereas large vacuole containing cells appeared
in both SVF and SVF–DLK1 cell cultures (data not shown). QRT-
PCR conﬁrmed this (Fig. 2), and revealed that DLK1+ cell cultures
entirely lacked adiponectin and contained much lower levels of
Cebpb (compared with SVF and SVF–DLK1), two adipogenic fac-
tors [35]. Surprisingly the DLK1+ cell cultures expressed relatively
high levels of vascular markers (Fig. 2), a proﬁle that was even
more pronounced compared to the freshly sorted cells. Further-
more, DLK1+ cells retained Dlk1 mRNA expression (Fig. 2) andFig. 4. DLK1+/CD45-SVF cells possess in vitro endothelial differentiation potential. Fres
differentiation. (A) Representative phase pictures from microscopic examinations (n = 6)
an endothelial morphology (scale bar 250 lm). (B) Shedded DLK1 persisted in DLK1+/CD4
Data were normalized to that of day 9 within each experiment. (C) DLK1+/CD45-SVF cel
shown), and this cell organization was maintained at least until day 6 as shown in the
endothelial differentiation were assessed by (D) microscopy (scale bar 100 lm), and (E)
LDL) uptake. Fibroblasts that lack LDL uptake [47] were used as a negative control f
experiments are shown.sDLK1 throughout adipogenic induction (data not shown), a sce-
nario that is in contrast to the DLK1 down-regulation seen in dif-
ferentiating 3T3-L1 cells [12,34].
3.3. SVF–CD45/DLK1+ cells become functional endothelial cells
in vitro
Since preadipocytes exclusively remain within the non-hemato-
poietic SVF [36,37], and may have been missed in the above exper-
iments due to the frequency of DLK1+/CD45+ cells, we also
analyzed the non-hematopoietic fraction of SVF–DLK1+ cells
(Fig. 3A). The SVF–CD45/DLK1+ population comprised
1.36 ± 0.35 (mean ± S.D.; n = 3, n* = 3) of live SVF cells. The purity
of sorted DLK1+/CD45 cells was 87.0 ± 2.6% (Fig. 3A), which was
conﬁrmed by PCR (Fig. 3B) and immunocytochemistry (Fig. 3C).
In agreement with ﬂowcytometry of the un-fractionated SVF–
DLK1+ population, immunocytochemistry conﬁrmed that SVF–
CD45/DLK1+ expressed CD31 (Fig. S4) and moreover showed that
DLK1+/CD45 cells expressed a-smooth muscle actin and desmin
(Fig. 3D), two markers of pericytes and smooth muscle cells [38],
but not preadipocytes (Fig. 3D). Following adipogenic induction
of SVF-CD45/DLK1+ cells, no adipocytes were observed in these
cultures and attempts to improve the adipogenic differentiation
milieu by replacing fetal calf serum with horse serum [39] were
also futile (Fig. 3E). Even after 18 days of adipogenic induction
we could not identify any mature Oil-red-O+ adipocytes in the
SVF–CD45/DLK1+ cell cultures (Fig. 3E), a time point where many
lipid ﬁlled adipocytes were seen in the SVF–CD45/DLK1 cell cul-
tures (Fig. 3F). Instead, SVF–CD45/DLK1+ cell cultures consisted of
many cobblestone areas with endothelial-like cells interspersed
between cells with a smooth muscle like phenotype (Fig. 3E).hly sorted DLK1+/CD45-SVF were cultured on ﬁbronectin for 9 days of endothelial
of DLK1+/CD45-SVF cell cultures revealed a rather homogenous layer of cells with
5-SVF conditioned medium obtained every third day of endothelial differentiation.
ls formed capillary-like structures as soon as 24 h after plating on matrigel (data not
ﬁgure (scale bar 250 lm). (D and E) DLK1+/CD45-SVF cells cultured for 9 days of
ﬂowcytometric analysis for DiI conjugated-acetylated-low density-lipoprotein (DiI-
or the LDL assay. For both (C)–(E) representative pictures from one out of three
2952 D.C. Andersen et al. / FEBS Letters 583 (2009) 2947–2953Unexpectedly, the collected data thus strongly suggested that the
SVF derived DLK1+ cell population is devoid of preadipocytes. Pre-
vious data have shown that adipogenesis requires DLK1 down reg-
ulation [23,34,35], and herein DLK1 remained present throughout
adipogenic differentiation, which may reﬂect that standard adipo-
genic culture conditions were insufﬁcient to initiate an adipogenic
program in SVF–DLK1+ cells and may have required a stronger adi-
pogenic inducer like rosiglitazone [40]. However, as these standard
conditions were adequate for adipogenesis of SVF–DLK1 cells
(Fig. 3F) and also results in downregulation of DLK1 in 3T3-L1 pre-
adipocytes [12], it seems more likely that DLK1 inhibits adipogen-
esis by acting on other cells that possess a natural cue to become
adipocytes. Alternatively, adipose CD45/DLK1+ cells could repre-
sent an early preadipocyte precursor not committed to the adipo-
genic lineage yet. Furthermore, other studies suggest a relation
between DLK1 and vasculature i.e. DLK1 in developing endothe-
lium [5] and DLK1 as a marker of brain pericytes [41]. To further
substantiate an endothelial phenotype of SVF–DLK1+ cells we cul-
tured sorted SVF–CD45/DLK1+ cells in an in vitro milieu that fa-
vors endothelial differentiation. More or less all SVF–CD45/
DLK1+ cells seemed to attain the typical morphology of endothelial
cells (Fig. 4A), and measurements of the sDLK1 content revealed
that sDLK1 was maintained during endothelial differentiation
(Fig. 4B). Similar to endothelial cells [42,43], SVF–CD45/DLK1+
cells also formed vessel-like structures on matrigel (Fig. 4C) and
importantly, they demonstrated LDL uptake (Fig. 4D–E), showing
an endothelial phenotype at the functional level as well. However,
a recent study has also described DLK1 in progenitor cells express-
ing EpCAM [44] (epithelial cell adhesion molecule) and since data
are rapidly emerging that appear to interlink epithelial and endo-
thelial progenitors [45], we cannot exclude the possibility that
the DLK1+ cells in SVF represent a common endothelial/epithelial
progenitor.
4. Concluding remarks
Altogether, our results thus suggest that the DLK1 protein
marks adipose residing vascular cells that lack adipogenic differen-
tiation potential, but possess an immediate capability for vascular
differentiation. The role of DLK1 in angiogenesis remains to be
determined, but during the draft of this paper, ADAM17, the prote-
ase that catalyzes the cleavage of membrane bound DLK1, was
shown to be involved in endothelial cell proliferation and angio-
genesis [46], features that may be partly mediated through the
DLK1 protein.
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